dabl® News - dabl Clinical Trials

OCT New England 2020 Sept 30 – Oct 1, Boston
16 Apr 2020

Let’s meet up at: Outsourcing in Clinical Trials (OCT) New England 2020, Sheraton Boston Hotel.

{...} click to continue

dabl ensures uninterrupted clinical trial workflow in COVID-19 pandemic
14 Apr 2020

The dabl ABPM system and ABPM device logistics service obviates hospital trial site visits during this COVID-19 pandemic resulting in uninterrupted workflow. The FDA Guidance on Conduct of Clinical Trials of Medical Products during the COVID-19 Pandemic – updated April 2, 2020 – allows for changes to be made to the investigational plan or protocol […]

{...} click to continue

DIA 2020 June 14-18 Washington DC (Virtual)
13 Apr 2020

Join us at the virtual experience of: Drugs Information Association (DIA) 2020 Conference and Exhibition, Walter E Washington Convention Center, 801 Mount Vernon Place NW Washington DC.

{...} click to continue

OCT Europe 2020 October 26-27, Paris
25 Feb 2020

Meet the dabl team at: Outsourcing in Clinical Trials (OCT) Europe 2020, Espace Grande Arche, Paris.

{...} click to continue

Swiss Biotech Day 2020 September 15, Basel

Let’s meet up at: Swiss Biotech Day Conference and Exhibition, Congress Center Basel, Messeplatz 21, 4058 Basel, Switzerland. See you there!

{...} click to continue

OCT West Coast 2020 March 3-4 San Francisco

Meet the dabl team at: Outsourcing in Clinical Trials (OCT) West Coast 2020, Hyatt Regency San Francisco Airport, 3rd-4th March, 2020. We would love to meet you there!

{...} click to continue

#Wear Red Day – February 1st 2019
01 Feb 2019

Why is dabl® Going RED? Cardiovascular diseases kill 1 woman every 80 seconds yet 80% of these cases may be prevented with education and action. According to the American Heart Association increasing physical activity, healthy eating and regularly monitoring your Blood Pressure will help enormously in preventing cardiovascular disease.      

{...} click to continue

Smart Wearables to Disrupt Clinical Trials
24 Jan 2019

Dublin, Ireland, January 24th 2019 – dabl, a company at the forefront of research and development in Blood Pressure Management and data analysis for almost twenty years, today announce an exciting new collaborative project in Wearable Technology. As part of a consortium led by Tyndall National Institute dabl will share in $8.7m (€7.5m) to develop […]

{...} click to continue

Hypertension and Chronic Obstructive Pulmonary Disease (COPD)
21 Nov 2018

Hypertension is a condition that prevails globally and is estimated to affect over one billion people. It occurs irrespective of income status but is more common with advancing age. Physical inactivity and increasing body weight are significant contributory factors to developing hypertension. On this, #WorldCOPDDay it is worth noting the correlation between COPD, hypertension and […]

{...} click to continue

Clinical Trials are a Waste of Time and Money – Are They?
15 Nov 2018

The cost of clinical trials is rising exponentially. The Tufts Centre for the Study of Drug Development has published data that indicates the average cost to develop and secure marketing approval for a new drug now exceeds $2.5 billion. Although the new industry model of outsourcing, in the form of Contract research Organisations, is seen as a step […]

{...} click to continue